CVS Health Corporation (CVS): Price and Financial Metrics
CVS Health Corporation (CVS)
Today's Latest Price: $76.26 USD
Updated Jan 15 7:00pm
Add CVS to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 6 in Medical - Drug Stores
See all "A" rated Strong Buy stocks
CVS Stock Summary
- CVS has a higher market value than 97.64% of US stocks; more precisely, its current market capitalization is $98,233,958,025.
- CVS HEALTH Corp's stock had its IPO on January 1, 1986, making it an older stock than 92.8% of US equities in our set.
- In terms of volatility of its share price, CVS is more volatile than just 7.5% of stocks we're observing.
- Stocks that are quantitatively similar to CVS, based on their financial statements, market capitalization, and price volatility, are TGT, AXP, SE, BKNG, and EL.
- CVS's SEC filings can be seen here. And to visit CVS HEALTH Corp's official web site, go to www.cvshealth.com.
CVS Stock Price Chart Interactive Chart >
CVS Price/Volume Stats
| Current price | $76.26 | 52-week high | $77.23 |
| Prev. close | $75.05 | 52-week low | $52.04 |
| Day low | $74.85 | Volume | 8,110,300 |
| Day high | $76.45 | Avg. volume | 8,048,030 |
| 50-day MA | $69.87 | Dividend yield | 2.62% |
| 200-day MA | $63.97 | Market Cap | 99.82B |
CVS Health Corporation (CVS) Company Bio
CVS Health Corporation provides integrated pharmacy health care services in the United States. The company operates through Pharmacy Services and Retail Pharmacy segments. The company was founded in 1892 and is based in Woonsocket, Rhode Island.
CVS Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $76.26 | $193.6 | 158% |
Below please find a table outlining a discounted cash flow forecast for CVS, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that CVS HEALTH Corp ranked in the 71th percentile in terms of potential gain offered. More precisely, our analysis suggests the stock is undervalued by approximately 159.17% on a DCF basis. In terms of the factors that were most noteworthy in this DCF analysis for CVS, they are:
- As a business, CVS is generating more cash flow than 96.1% of positive cash flow stocks in the Healthcare.
- 53% of the company's capital comes from equity, which is greater than only 22.33% of stocks in our cash flow based forecasting set.
- CVS HEALTH Corp's weighted average cost of capital (WACC) is 7%; for context, that number is higher than merely 1.83% of tickers in our DCF set.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | 153% |
| 1% | 155% |
| 2% | 158% |
| 3% | 160% |
| 4% | 163% |
| 5% | 166% |
For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as CVS, try ESMC, FTLF, ALXN, SGRY, and ENSG.
Loading social stream, please wait...